Meghan M. StuerAssociateSheppard, Mullin, Richter & Hampton LLPWebsitewww.sheppardmullin.comOrganization ProfileFull ProfileConnectEmail212.634.3028 Professional Biography Meghan M. Stuer is an associate in the Business Trial Practice Group in the firm's New York office. Before joining the firm, she was a summer associate with Sheppard Mullin Law Firm. More Legal and Business Bylines From Meghan M. Stuer SEC Shifts Focus on Employees’ Off-Channel Business Communications to Investment Advisers - (Posted On Friday, November 11, 2022) New York Courts Continue to Enforce Broad General Releases, Even When Claims are Unforeseeable at the Time of Contract Execution - (Posted On Friday, July 30, 2021) Commercial Division Rule Revisions Continue to Promote Efficiency in Complex Cases - (Posted On Wednesday, August 01, 2018) Current Legal Analysis Scrutiny on Financial Institutions Compliance Expected to Increase During Trump Administration by: Mark D. Nelson President Trump’s Executive Orders on Immigration and What They Mean for Employers by: Otieno B. Ombok , Amy L. Peck US Treasury and IRS Unveil Proposed Regulations for Commercial EV Tax Credit, Sparking Questions on Recapture Provisions by: Chris DiAngelo , Brandon D. Hadley At Long Last, DEA’s Remote Prescribing Rules 2.0 Are (Really) Here! (Pending Further Consideration by the Incoming Administration . . .) by: Alan J. Arville , Audrey Davis The TikTok Ban Saga: SCOTUS, Trump’s Executive Order, and the Implications for Digital Marketing and Emerging Platforms by: Jeffrey M. Kelly FTC Announces Significant Increases to the 2025 HSR Reporting Thresholds by: Carrie A. Hanger , Colleen Pleasant Kline New TTB Standard of Fill No Place for Kegged Cocktails by: Benjamin Sheppard 60-Second Sustains: The Mission Essential Group by: Elizabeth N. Jochum , David L. Bodner Upcoming Events Jan 22 2025 Employee Activism and the Issues It Can Create Jan 22 2025 The SEC under President Trump: A Preview Jan 22 2025 Transgender Employees and Related Issues in the Workplace Jan 28 2025 Antibody Drug Conjugates Keep Growing: What You Need to Know Print
